Back to Search
AMY HOWELL, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1730389230Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
2008-00916(NC)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
2008-00916(NC)
Research & Publications (20)
Energy restriction for breast cancer prevention.
PMID 19213562·Recent Results Cancer Res·2009
6-review
Response and resistance to the endocrine prevention of breast cancer.
PMID 18497044·Adv Exp Med Biol·2008
6-review
The endocrine prevention of breast cancer.
PMID 18971122·Best Pract Res Clin Endocrinol Metab·2008
6-review
Should lifestyle modifications be promoted to prevent breast cancer?
PMID 19128424·Breast Cancer Res·2008
8-other
Setting the stage: early child and family characteristics as predictors of later loneliness in children with developmental disabilities.
PMID 17181387·Am J Ment Retard·2007
8-other
Estrogen deprivation for breast cancer prevention.
PMID 17302193·Recent Results Cancer Res·2007
6-review
Is fulvestrant ("Faslodex") just another selective estrogen receptor modulator?
PMID 17010063·Int J Gynecol Cancer·2006
6-review
Pure oestrogen antagonists for the treatment of advanced breast cancer.
PMID 16954425·Endocr Relat Cancer·2006
6-review
The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer.
PMID 18473974·Rev Recent Clin Trials·2006
2-rct
Fulvestrant ('Faslodex'): current and future role in breast cancer management.
PMID 16473018·Crit Rev Oncol Hematol·2006
6-review
Are aromatase inhibitors superior to antiestrogens?
PMID 15860266·J Steroid Biochem Mol Biol·2005
4-observational
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.
PMID 15937908·Cancer·2005
3-trial
Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions.
PMID 16341119·Nat Clin Pract Oncol·2005
6-review
Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer.
PMID 16277879·Clin Breast Cancer·2005
6-review
New developments in the treatment of postmenopausal breast cancer.
PMID 16213745·Trends Endocrinol Metab·2005
6-review
Overview of the impact of conventional systemic therapies on breast cancer.
PMID 16113103·Endocr Relat Cancer·2005
6-review
Selective oestrogen receptor modulators, aromatase inhibitors and the female breast.
PMID 15976552·Curr Opin Obstet Gynecol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
4.5(22)
- Address
- 2609 WEST ARLINGTON BLVD, SUITE 106
GREENVILLE, NC 27834 - Phone
- (252) 689-6303
- Website
- contentnea.org
4.5(22)
See full reviewsQuick Facts
- NPI
- 1730389230
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile